Home TearLab Corporation

TearLab Corporation

TearLab Announces Acquisition By Accelmed and Related $25 Million Investment

In connection with the acquisition, AP-II has agreed to an investment of $25 million over two tranches that will occur in conjunction with the company delisting from the "over the counter" OTCQB market and TearLab and its senior secured lender, CR Group, has agreed to restructure the terms of the company's outstanding senior secured indebtedness.